Cargando…

Influence of serum cholesterol level and statin treatment on prostate cancer aggressiveness

Both cholesterol levels and the use of statins have been described to influence the development and prognosis of prostate cancer (PC). In this retrospective, cross-sectional analysis of consecutive cases from a tertiary referral center we evaluated an association between hypercholesterolemia (≥5.0mm...

Descripción completa

Detalles Bibliográficos
Autores principales:	Schnoeller, Thomas J., Jentzmik, Florian, Schrader, Andres J., Steinestel, Julie
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2017
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5564548/ https://www.ncbi.nlm.nih.gov/pubmed/28445145 http://dx.doi.org/10.18632/oncotarget.16943

Ejemplares similares

High CRP values predict poor survival in patients with penile cancer
por: Steffens, Sandra, et al.
Publicado: (2013)

Elevated C-reactive protein values predict nodal metastasis in patients with penile cancer
por: Al Ghazal, Andreas, et al.
Publicado: (2013)

The Retrourethral Transobturator Sling Suspension in the Treatment of Male Urinary Stress Incontinence: Results of a Single Institution Experience
por: Mueller, Johannes, et al.
Publicado: (2012)

Detecting predictive androgen receptor modifications in circulating prostate cancer cells
por: Steinestel, Julie, et al.
Publicado: (2015)

Partial nephrectomy using porcine small intestinal submucosa
por: Schnoeller, Thomas J, et al.
Publicado: (2011)

The role of histologic subtype, p16(INK4a) expression, and presence of human papillomavirus DNA in penile squamous cell carcinoma
por: Steinestel, Julie, et al.
Publicado: (2015)

Influence of Statins on Survival Outcome in Patients with Metastatic Castration Resistant Prostate Cancer Treated with Abiraterone Acetate
por: Boegemann, Martin, et al.
Publicado: (2016)

Role of Serum Cholesterol and Statin Use in the Risk of Prostate Cancer Detection and Tumor Aggressiveness
por: Morote, Juan, et al.
Publicado: (2014)

Low-dose statin treatment increases prostate cancer aggressiveness
por: Caro-Maldonado, Alfredo, et al.
Publicado: (2017)

Clinical significance of epithelial-mesenchymal transition
por: Steinestel, Konrad, et al.
Publicado: (2014)

Positive surgical margins in nephron-sparing surgery: risk factors and therapeutic consequences
por: Steinestel, Julie, et al.
Publicado: (2014)

Impact of prescription size on statin adherence and cholesterol levels
por: Batal, Holly A, et al.
Publicado: (2007)

Morbidity and Quality of Life in Bladder Cancer Patients following Cystectomy and Urinary Diversion: A Single-Institution Comparison of Ileal Conduit versus Orthotopic Neobladder
por: Erber, Barbara, et al.
Publicado: (2012)

Cholesterol Serum Levels and Use of Statins in Graves' Orbitopathy: A New Starting Point for the Therapy
por: Lanzolla, Giulia, et al.
Publicado: (2020)

Decreasing cholesterol levels in the community – lifestyle change with statin?
por: Savolainen, Jorma, et al.
Publicado: (2015)

Influence of Previous Statin Therapy on Cholesterol-Lowering Effect of Ezetimibe
por: Choi, Young Hwan, et al.
Publicado: (2014)

Overexpression of p16(INK4a) in Urothelial Carcinoma In Situ Is a Marker for MAPK-Mediated Epithelial-Mesenchymal Transition but Is Not Related to Human Papillomavirus Infection
por: Steinestel, Julie, et al.
Publicado: (2013)

Statin Use, Cholesterol Level, and Mortality Among Females With Breast Cancer
por: Murto, Mika O., et al.
Publicado: (2023)

Cholesterol, Statins, and Alzheimer Disease
por: Koudinov, Alexei R, et al.
Publicado: (2005)

Apolipoprotein E gene polymorphism influences aggressive behavior in prostate cancer cells by deregulating cholesterol homeostasis
por: IFERE, GODWIN O., et al.
Publicado: ( 201)

Survival advantage of partial over radical nephrectomy in patients presenting with localized renal cell carcinoma
por: Roos, Frederik C, et al.
Publicado: (2014)

Pre-Treatment with Statins for Coronary Intervention: Pleiotropy of Statins or Effect of LDL-cholesterol Reduction?
por: Habon, Tamas, et al.
Publicado: (2016)

Association of serum cholesterol with Parkinson's disease in a cohort of statin‐free individuals
por: Lv, Yukai, et al.
Publicado: (2021)

Inverse Association between Statin Use and Cancer Mortality Relates to Cholesterol Level
por: Peltomaa, Antti I., et al.
Publicado: (2022)

The Role of the Neutrophil to Lymphocyte Ratio for Survival Outcomes in Patients with Metastatic Castration-Resistant Prostate Cancer Treated with Abiraterone
por: Boegemann, Martin, et al.
Publicado: (2017)

‘Real-life’ reduction in cholesterol with statins, 1993 to 2002
por: Murphy, Michael J, et al.
Publicado: (2008)

Optimal target of LDL cholesterol level for statin treatment: challenges to monotonic relationship with cardiovascular events
por: Sakuma, Masashi, et al.
Publicado: (2022)

Statins: Cholesterol guidelines and Indian perspective
por: Menon, Anil S., et al.
Publicado: (2015)

Cholesterol suppresses antimicrobial effect of statins
por: Haeri, Mohammad Reza, et al.
Publicado: (2015)

Cholesterol Levels and Statin Use in Patients With Coronary Heart Disease Treated in Primary Care Settings
por: O’Connor, Patrick J, et al.
Publicado: (2005)

Serum lipid profiles and aggressive prostate cancer
por: Li, Yanjing, et al.
Publicado: (2015)

Aggression in Women with Schizophrenia Is Associated with Lower HDL Cholesterol Levels
por: Herceg, Dora, et al.
Publicado: (2022)

Statin Effects on Aggression: Results from the UCSD Statin Study, a Randomized Control Trial
por: Golomb, Beatrice A., et al.
Publicado: (2015)

Statins redux: A re-assessment of how statins lower plasma cholesterol
por: Raghow, Rajendra
Publicado: (2017)

Serum cholesterol levels and tumor growth in a PTEN-null transgenic mouse model of prostate cancer
por: Allott, Emma H., et al.
Publicado: (2018)

Cholesterol treatment with statins: Who is left out and who makes it to goal?
por: Franks, Peter, et al.
Publicado: (2010)

Comparison of circulating tumor cells and AR-V7 as clinical biomarker in metastatic castration-resistant prostate cancer patients
por: Schlack, Katrin, et al.
Publicado: (2022)

Racial Differences in the Cholesterol-Lowering Effect of Statin
por: Naito, Ryo, et al.
Publicado: (2017)

Testosterone treatment and the risk of aggressive prostate cancer in men with low testosterone levels
por: Walsh, Thomas J., et al.
Publicado: (2018)

Serum Fucosylated Prostate-specific Antigen (PSA) Improves the Differentiation of Aggressive from Non-aggressive Prostate Cancers
por: Li, Qing Kay, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_fb3713gujmbqaad5kqq72oqeud